Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Triveni Kothapalli

YOU WONT BELIEVE: Avidity biosciences soars after 72 per share novartis takeover | Mind Blowing Facts

Genetic,Research,And,Biotech,Science,Concept.,Human,Biology,And,Pharmaceutical

Avidity Biosciences, Inc. (NASDAQ:RNA) stock surged after announcing a $12 billion all-cash acquisition by Novartis AG (NYSE:NVS), marking one of the largest biotech buyouts of the year.

Analyst Downgrade Matches $72 Per Share Offer

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.